Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Posted on

Application Deadline

Type

Research/project funding

Reference Number

PAR-22-028

The purpose of this FOA is to provide investigators with a mechanism to access contract research/medical organizations (CROs/CMOs) and subject matter experts (SMEs) within the NINDS Ultra-Rare Gene-based Therapy (URGenT) Network to support planning, manufacturing, and limited nonclinical therapeutic development efforts.
Categories: Health.

More Information

Visit Website

Posted on

Application Deadline

Type

Research/project funding

Reference Number

PAR-22-028

United States